Sulphur-scented burping affects roughly 10-15% of people taking GLP-1 receptor agonists like tirzepatide, though the symptom typically improves within weeks of starting treatment
Both are powerful antioxidants that help protect cells in the heart against free-radical damage
Side effects are rare and mild, most commonly involving slight bruising or itching at the injection site
Retatrutide is not yet approved, and experts warn that misuse or black market sourcing carries real risks, from incorrect dosing to unknown compounds
On this page, well discuss the ongoing Ozempic Lawsuit, the establishment of the Ozempic MDL for health effects from GLP 1 receptor agonist (RA) weight loss drugs, the risk of severe gastroparesis (stomach paralysis) from these drugs, how an Ozempic lawyer can help, and much more